One of the reasons why ketamine has gained interest in the field of mental health is because of its ability to induce a dissociative state, which can sometimes resemble a near-death experience (NDE). A near-death experience is a profound psychological event typically reported by individuals who have come close to dying or experienced a life-threatening situation. Common features of NDEs include a feeling of detachment from the body, a sensation of traveling through a tunnel, encounters with deceased loved ones, and a feeling of overwhelming peace and tranquility.
The similarities between the dissociative state induced by ketamine and the reported experiences of those who have had a near-death experience have led researchers to explore the potential therapeutic benefits of ketamine. It is believed that the dissociative effects of ketamine can help patients gain a new perspective on their lives, which may result in improved mood, reduced anxiety, and a greater sense of well-being.
However, it is important to note that not everyone who receives therapeutic ketamine will have a near-death-like experience. The effects of ketamine can vary significantly between individuals, and the specific experiences reported during treatment may be influenced by factors such as dose, administration method, and individual psychological factors.
Berman, R. M., Cappiello, A., Anand, A., Oren, D. A., Heninger, G. R., Charney, D. S., & Krystal, J. H. (2000). Antidepressant effects of ketamine in depressed patients. Biological Psychiatry, 47(4), 351-354. URL: https://doi.org/10.1016/S0006-3223(99)00230-9
Zarate, C. A., Singh, J. B., Carlson, P. J., Brutsche, N. E., Ameli, R., Luckenbaugh, D. A., Charney, D. S., & Manji, H. K. (2006). A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Archives of General Psychiatry, 63(8), 856-864. URL: https://doi.org/10.1001/archpsyc.63.8.856
Krupitsky, E. M., & Grinenko, A. Y. (1997). Ketamine psychedelic therapy (KPT): A review of the results of ten years of research. Journal of Psychoactive Drugs, 29(2), 165-183. URL: https://doi.org/10.1080/02791072.1997.10400185